Kian Ahmadieh, MD
Urology · Gilbert, AZNPI 1932697190
Payments from drug & device makers
What this record shows
This record is dominated by grants: $15,000 of the $18,853 with a category attached, or 79.6%. Boston Scientific accounts for 91.5% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $15,720, more than ten times the $125 reported in 2019.
Across 58 payments — averaging $325.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$17K
- Coloplast$372
- Procept Biorobotics Corporation$327
- Axonics, Inc.$227
- Innovation Technologies Inc$150
- C. R. Bard, Inc. & Subsidiaries$113
- plus $405 from 10 others
What the payments were for
- Grants$15,00080%
- Travel & lodging$9975%
- Food & beverage$2,85615%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $17,259 |
| Coloplast | 5 | $372 |
| Procept Biorobotics Corporation | 4 | $327 |
| Axonics, Inc. | 4 | $227 |
| Innovation Technologies Inc | 1 | $150 |
| C. R. Bard, Inc. & Subsidiaries | 5 | $113 |
| Medtronic | 1 | $90 |
| Progenics Pharmaceuticals, Inc. | 3 | $58 |
| Integra Lifesciences Corporation | 3 | $51 |
| Calyxo, Inc. | 1 | $48 |
| 180 Medical, Inc. | 2 | $47 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $22 |
| Laborie Medical Technologies Corp. | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $21 |
| Endo USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,853 in reported general payments places this provider in the 85th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $19,013 |
| Trospium Chloride ErTrospium Chloride | 11 | $2,881 |
| Tamsulosin Hcl | 86 | $1,164 |
| Solifenacin Succinate | 14 | $545 |
| Finasteride | 33 | $484 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $192 |
| Doxycycline Hyclate | 11 | $112 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $54 |
Paid to pharmacies, not to this prescriber.
Other urology in Gilbert
- Chinedu MmejeGilbert$114K
- John LinGilbert$108K
- Pratik PatelGilbert$58K
- Frank SimonciniGilbert$11K
- Devin PatelGilbert$11K
- Mitchell HumphreysPhoenix$358K
- Shawn BlickGoodyear$336K
- Daniel JaffeePhoenix$280K
- Rahul MehanMesa$277K
- Mitzi BarmatzTucson$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.